2002
DOI: 10.1016/s0015-0282(02)03656-7
|View full text |Cite
|
Sign up to set email alerts
|

Endocrine and clinical profiles of controlled ovarian stimulation (COS): improved features in human menopausal gonadotropin (hMG) vs. recombinant human follicle-stimulating hormone (r-hFSH) treatment

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles